Takuya Araki

591 total citations
51 papers, 457 citations indexed

About

Takuya Araki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Takuya Araki has authored 51 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Takuya Araki's work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Takuya Araki is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Takuya Araki collaborates with scholars based in Japan, United States and Australia. Takuya Araki's co-authors include Koujirou Yamamoto, Tomonori Nakamura, Kimihiro Shimizu, Kyoichi Kaira, Izumi Takeyoshi, Seiichi Kakegawa, Tohru Aomori, Tadahiro Hashita, Yoshihisa Nojima and Katsunori Nakamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of Colloid and Interface Science.

In The Last Decade

Takuya Araki

44 papers receiving 448 citations

Peers

Countries citing papers authored by Takuya Araki

Since Specialization

Citations

This map shows the geographic impact of Takuya Araki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Araki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Araki more than expected).

Fields of papers citing papers by Takuya Araki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Araki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Araki. The network helps show where Takuya Araki may publish in the future.

Co-authorship network of co-authors of Takuya Araki

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Araki. A scholar is included among the top collaborators of Takuya Araki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Araki. Takuya Araki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma concentrations of doxorubicin and cyclophosphamide during anthracycline-based chemotherapy in a pregnant breast cancer patient: evaluation of gestational changes 2026 ·Cancer Chemotherapy and Pharmacology ·(unknown), Takuya Araki, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Koujirou Yamamoto	0
2	Effect of dasatinib on blood concentrations of sunitinib and adverse events in a patient with metastatic renal cell carcinoma treated with sunitinib: A case report 2025 ·Experimental and Therapeutic Medicine ·(unknown), (unknown), Takuya Araki, Masashi Nomura, Kazuhiro Suzuki, Koujirou Yamamoto	2
3	Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment 2024 ·Cancer Chemotherapy and Pharmacology ·(unknown), Takuya Araki, (unknown), (unknown), Jun Morita, (unknown), Masayuki Ohbayashi, Noriko Kohyama, Yoshio Ogawa, Takashi Fukagai, Koujirou Yamamoto, (unknown)	1
4	Increased c‑SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma 2023 ·Oncology Letters ·(unknown), Takuya Araki, (unknown), (unknown), (unknown), Koujirou Yamamoto	4
5	Risk of exposure of patients’ family members to lenalidomide at home 2023 ·European Journal of Hospital Pharmacy ·(unknown), (unknown), (unknown), (unknown), (unknown), Takuya Araki, Koujirou Yamamoto	0
6	Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin 2023 ·SHILAP Revista de lepidopterología ·(unknown), Takuya Araki, (unknown), Yoshiyuki Miyazawa, Kazuhiro Suzuki, Koujirou Yamamoto	0
7	Sequential and simultaneous ion transfer into carbon nanopores during charge–discharge cycles in electrical double layer capacitors 2022 ·Sustainable Energy & Fuels ·(unknown), (unknown), Takuya Araki, Koki Urita, Koki Urita, Tomonori Ohba	8
8	Effect of processing step and condition for Japanese green tea manufacturing process on structural attribute of tea leaves and antioxidant activity of tea infusion 2018 ·Wei Qin, (unknown), Takuya Araki, (unknown), Yukiharu Ogawa	2
9	Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients 2018 ·European Journal of Clinical Pharmacology ·(unknown), Takuya Araki, (unknown), Yoshiyuki Ogawa, (unknown), Hideki Uchiumi, Hiroshi Handa, Tomonori Nakamura, Koujirou Yamamoto	4
10	Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A53/3 2017 ·Biochemical Genetics ·(unknown), (unknown), Tadahiro Hashita, Tohru Aomori, Keiju Hiromura, Yoshihisa Nojima, Tomonori Nakamura, Takuya Araki, Koujirou Yamamoto	20
11	Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients 2014 ·Molecular and Clinical Oncology ·(unknown), Kimihiro Shimizu, Takuya Araki, Tohru Aomori, Yoichi Ohtaki, Toshiteru Nagashima, (unknown), Jun Atsumi, Tomonori Nakamura, Izumi Takeyoshi, Koujirou Yamamoto	9
12	Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients 2013 ·Drugs in R&D ·(unknown), Takuya Araki, Katsunori Nakamura, Masahiko Kurabayashi, Yoshihisa Nojima, (unknown), Tomonori Nakamura, Koujirou Yamamoto	31
13	Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus 2012 ·American Journal of Health-System Pharmacy ·(unknown), Miki Takenaka, Tohru Aomori, Yuko Okada, Keiju Hiromura, Yoshihisa Nojima, Takuya Araki, Tomonori Nakamura, Koujirou Yamamoto	4
14	Effect of Ethanol in Paclitaxel Injections on the Ethanol Concentration in Exhaled Breath 2012 ·Drugs in R&D ·Tohru Aomori, (unknown), (unknown), Tadahiro Hashita, Takuya Araki, (unknown), Tomonori Nakamura, Koujirou Yamamoto	8
15	Clinicopathological features of lung adenocarcinoma with KRAS mutations 2011 ·Cancer ·Seiichi Kakegawa, Kimihiro Shimizu, (unknown), (unknown), Kyoichi Kaira, Takuya Araki, Tetsuhiro Nakano, Mitsuhiro Kamiyoshihara, Osamu Kawashima, Izumi Takeyoshi	52
16	Predicting cetuximab accumulation in KRAS wild‐type and KRAS mutant colorectal cancer using ⁶⁴Cu‐labeled cetuximab positron emission tomography 2011 ·Cancer Science ·(unknown), Hirofumi Hanaoka, Hiroki Yoshioka, Shinji Yamamoto, Hideyuki Tominaga, Takuya Araki, Yasuhiro Ohshima, Noboru Oriuchi, Keigo Endo	30
17	A case of fatal drug intoxication showing a high-density duodenal content by postmortem computed tomography 2010 ·Legal Medicine ·Rie Sano, Keiko Takahashi, Yoshihiko Kominato, Takuya Araki, (unknown), Hiroyuki Takei, (unknown), (unknown), (unknown), (unknown), Hideo Aoki	7
18	Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded Lung Cancer Tissue 2010 ·Journal of Molecular Diagnostics ·(unknown), Kimihiro Shimizu, Yasumasa Mitani, Takuya Araki, Yuki Kawai, Masaru Baba, Seiichi Kakegawa, (unknown), Kyoichi Kaira, Alexander Lezhava, Yoshihide Hayashizaki, Koujirou Yamamoto, Izumi Takeyoshi	36
19	Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon12 Mutations in Lung Adenocarcinoma 2009 ·Journal of Molecular Diagnostics ·Takuya Araki, Kimihiro Shimizu, Katsunori Nakamura, Tomonori Nakamura, Yasumasa Mitani, (unknown), Yukiyoshi Fujita, Seiichi Kakegawa, (unknown), Kyoichi Kaira, Takefumi Ishidao, Alexander Lezhava, Yoshihide Hayashizaki, Izumi Takeyoshi, Koujirou Yamamoto	31
20	Influence of Wind Velocity Fluctuation on Air Temperature Difference between the Fan and Ground Levels and the Effect of Frost Protective Fan Operation 2008 ·Chagyo Kenkyu Hokoku (Tea Research Journal) ·Takuya Araki, Kiyoshi Matsuo, (unknown), (unknown), Shinsuke Araki	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact